Topics on OncologyPRO
Categorised scientific content throughout OncologyPRO
What does this mean?
- Topics pages: these allow you to go directly to your topic of interest and get a list of all content on OncologyPRO that has been tagged with this topic. This list is sorted by date so the most recent information appears at the top.
- What's the latest in: this box, available on the OncologyPRO homepage, allows you to go directly to your topic page of interest.
- Filtered lists: you can filter news and meeting resources lists by selecting the topic in the scroll-down bar above the list.
- Refined searches: all search areas across the site allow you to refine results by topic by using the left-hand ‘Refine’ options.
Where does this list come from?
The topics chosen to categorise OncologyPRO were extracted from the Global Curriculum in Medical Oncology. For simplicity, a sub-set of topics which cover the whole curriculum were selected keeping a 2-level taxonomy for OncologyPRO.
What is the taxonomy used on OncologyPRO?
Basic Science: includes research done in vitro and in animal models.
Bioethics, Legal,and Economic Issues: includes informed consent, research ethics, ethical and legal issues in end-of-life care, cost effectiveness of cancer drugs, conflict of interest and professional conduct.
- Career Development: includes Young Oncologist sessions at events, how-to tips, and fellowship information.
Cancer Aetiology, Epidemiology, Prevention: includes primary and secondary screening.
- Cancer in Adolescents
- Cancer in Young Adults
- Cancer in Pregnancy
- Geriatric Oncology
- Familial Cancer
- Genetic Syndromes related Cancers
- AIDS-associated malignancies
- Oesophageal Cancer
- Gastric Cancer
- Anal Cancer
- Hepatobiliary Cancers
- Colon Cancer
- Rectal Cancer
- Pancreatic Cancer
- Small-Cell Lung Cancer
- Non-Small Cell Lung Cancer, Early Stage
- Non-Small Cell Lung Cancer, Locally Advanced
- Non-Small Cell Lung Cancer, Metastatic
- Thymoma and Thymic Cancer
- Complications of Treatment: includes infections, Alopecia, bleeding and thrombosis, cardiovascular toxicity, catheter management, electrolyte disorders, endocrine and metabolic complications, fatigue, gastrointestinal complications, hepatotoxicity, hypersensitivity, infertility/sterility/sexuality, lymphedoema, myelosuppression, nephrotoxicity, neurotoxicity, oral complications, pulmonary toxicity, second malignancy, and skin toxicity.
- Supportive Care: includes nausea and vomiting, infections and neutropenia, anaemia, thrombocytopenia, marrow and peripheral-blood progenitor cells, organ protection, mucositis, malignant effusions, extravasation, oncologic emergencies, paraneoplastic syndromes, and nutritional support.
- Psychosocial Aspects of Cancer: includes the evaluation and management of psychological and existential symptoms of cancer.
- Palliative Care: includes end-of-life care, interdisciplinary care, pain management, symptom evaluation and management (dyspnoea, nausea and vomiting, constipation, diarrhoea, cancer-related fatigue, delirium, anorexia/cachexia and starvation), management of complications of cancer, communication, cultural competence, self care, and rehabilitation.
Personalised Medicine: only includes treatments with proven biomarkers (those under investigation are found in "Translational Research")
- Biomarkers: only includes biomarkers which have been proven (others are found in "Translational Research")